Skyrocketing 108% since the start of 2025, Tempus AI (NASDAQ: TEM), a company applying AI solutions to healthcare, has seen ...

DeepSeek is a stark reminder about the importance of strategic durability, and not just growth or growth potential, to a ...

A remarkable start to the year, marked by a 160% surge, has had investors paying close attention to healthcare tech company ...

Cathie Wood and Ark Invest moved to acquire Transfus AI (TEM, Financial) shares after its share price dropped by 1.5%. Wood's ...

Cathie Wood and Ark Invest seized the opportunity on Tuesday to buy the dip on Tempus AI ( NASDAQ: TEM) as the stock took a ...

Piper Sandler lowered the firm’s price target on Tempus AI (TEM) to $55 from $70 following quarterly results. The firm keeps a Neutral rating ...

Tempus AI's Q4 financials were slightly below expectations but aligned with preliminary results. See why I remain bullish on ...

Cathie Wood‘s Ark Invest executed significant trades involving Airbnb Inc. (NASDAQ:ABNB), Coinbase Global Inc. (NASDAQ:COIN), ...

Tempus AI (NASDAQ:TEM – Get Free Report) was downgraded by stock analysts at JPMorgan Chase & Co. from an “overweight” rating ...

We recently published an article titled Two of 10 Worst-Performing Stocks Fall to All-Time Lows on Tuesday. In this article, ...

Tempus AI held its IPO in June 2024 and is applying AI solutions to healthcare. Investors should watch several metrics to assess the company's growth prospects. While Tempus AI could reap big ...

Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) was up 12.7% on Wednesday after Needham & Company LLC raised their price target on the stock from $56.00 to $70.00. Needham & Company LLC currently has a ...